Spiroligomer Molecules Platform
exploratoryplatform · high · Wed Nov 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Develop synthetic, modular, fused-ring Spiroligomer molecules with controlled shapes and diverse functional groups for selective protein binding in drug discovery, therapeutics, and diagnostics.
Design and synthesize large libraries of chemically diverse Spiroligomer compounds intended to combine biologic-like selectivity with small-molecule-like stability, cell permeability, protease resistance, non-immunogenicity, and potential oral bioavailability.
ThirdLaw Molecular rebranded as Ladder Bio and announced a $5.5M seed financing led by Medical Excellence Capital.